Trials / Completed
CompletedNCT02068105
A Study of ALKS 5461 in Healthy Volunteers
A Phase 1, Randomized, Two-part Study to Evaluate the Relative Bioavailability of Two Formulations of ALKS 5461 and the Effect of Dose Titration of ALKS 5461 in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 104 (actual)
- Sponsor
- Alkermes, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
This is a study to test the safety of ALKS 5461 in healthy adults.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ALKS 5461 | Sublingual tablet |
| DRUG | Placebo | Sublingual tablet |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2014-03-01
- Completion
- 2014-03-01
- First posted
- 2014-02-21
- Last updated
- 2014-04-21
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02068105. Inclusion in this directory is not an endorsement.